Waycross Partners’s BioMarin Pharmaceuticals BMRN Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-7,000	Closed	-$619K	–	84
2023 Q3	$619K	Hold	7,000	–	–	0.14%	71
2023 Q2	$607K	Hold	7,000	–	–	0.13%	76
2023 Q1	$681K	Hold	7,000	–	–	0.2%	64
2022 Q4	$724K	Buy	7,000 +600	+9%	+$62.1K	0.26%	58
2022 Q3	$543K	Hold	6,400	–	–	0.37%	68
2022 Q2	$530K	Hold	6,400	–	–	0.35%	67
2022 Q1	$493K	Hold	6,400	–	–	0.29%	72
2021 Q4	$565K	Buy	6,400 +1,800	+39%	+$159K	0.32%	72
2021 Q3	$356K	Hold	4,600	–	–	0.22%	83
2021 Q2	$384K	Hold	4,600	–	–	0.2%	71
2021 Q1	$347K	Hold	4,600	–	–	0.19%	79
2020 Q4	$403K	Buy	+4,600	New	+$403K	0.25%	70